RemedyMD set to deliver 100 specialized disease registry software

Download PDF Copy

Reviewed

Oct 23 2009

RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.

Details about the registry: www.remedymd.com/cer100/

Developed to support the Institute of Medicine’s 100 top priorities for comparative effectiveness research (CER), these registries allow users to:

Access existing data stores
Easily collect new data elements
Report across all phenotypic and genotypic data simultaneously

As a result, clinicians and researchers will be able to dramatically improve their effectiveness as they search for which interventions are most appropriate for specific patient populations.

“Our experience has shown that when you view and report across all data types at the same time, you discover patterns and associations that were previously indistinguishable using traditional methodologies,” said Gary Kennedy, Founder and CEO of RemedyMD.

RemedyMD’s disease registry software effectively utilizes a combination of applications, tools and data infrastructure enabling clinicians and researchers to electronically collect and validate data, access and leverage other non-centralized data stores, while reporting and visualizing trends across all data types simultaneously.

“We’ve invested heavily over the past several years developing a platform that allows us to quickly create and personalize specialty-specific registries that address the requirement of AHRQ grants for CER,” said Adam Slovik, President and COO of RemedyMD. “Our Mosaic platform allows researchers to leverage disparate data sources, collaborate with colleagues and personalize research initiatives all without the help of IT.”

For more information about comparative effectiveness research and clinical registries visit: http://www.remedymd.com/cer100/.